Glimepiride
Glimepiride is a sulphonylurea used in type 2 diabetes. Its label treats hypoglycaemia as the defining risk of the medicine, and it names one drug interaction that can produce it severely.
Glucophage Trio
Type 2 Diabetes Mellitus
1mg + 0.2mg + 500mg
Utilised to manage complex glycaemic fluctuations to alleviate chronic hyperglycaemia and support tissue insulin sensitivity.
Key points
- The label states plainly that hypoglycaemia may be severe.
- It directs a 1 mg starting dose with slow titration in patients at increased risk of hypoglycaemia.
- Severe hypoglycaemia can occur when glimepiride and oral miconazole are used together.
- Postmarketing hypersensitivity reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome.
How it works
Glimepiride is a sulphonylurea. Medicines in this class prompt the pancreas to release more insulin, which is why they can lower blood sugar too far in a way that metformin, acting differently, generally does not. That mechanism is the direct reason hypoglycaemia is the risk that shapes how the medicine is started and monitored.
Safety specific to glimepiride
Hypoglycaemia. The label’s warning is short and unqualified: hypoglycaemia may be severe. It is not framed as an occasional nuisance, and it drives the dosing instruction that follows.
Starting dose. The label directs use of a 1 mg starting dose and slow titration in patients at increased risk for hypoglycaemia. Starting low and moving slowly is the mitigation, which is why a dose that suited someone else is not a guide to what suits you.
Miconazole. Severe hypoglycaemia can occur when glimepiride and oral miconazole are used concomitantly. Miconazole is an antifungal, and this is exactly the kind of interaction that gets missed when a medicine is prescribed for something apparently unrelated, so the full medicine list matters.
Hypersensitivity. Postmarketing reports include anaphylaxis, angioedema and Stevens-Johnson Syndrome. These are rare but serious, and a spreading rash, facial or throat swelling, or difficulty breathing after starting glimepiride needs emergency attention rather than observation.
When to seek urgent care
Symptoms of severe low blood sugar, including confusion, difficulty rousing or loss of consciousness, need emergency treatment. So do facial or throat swelling, difficulty breathing, or a spreading blistering rash.
Further reading
Related articles
28 Jul 2026 ⋅ 9 min read
Ramadan and Your Medication: Timing, Fasting and What Not to Stop
Fasting changes when you take most medicines, not whether you need them. What to raise with your doctor before Ramadan, which medicines carry real risk during a fast, and why stopping a chronic medicine quietly is the dangerous option.
Read guide
28 Jul 2026 ⋅ 9 min read
Type 2 Diabetes: Why Early Diagnosis Matters More Than It Sounds
Type 2 diabetes symptoms can be mild enough to go unnoticed for years, so it is often diagnosed after complications have already started. What to watch for, what the treatments do, and why more than half of people with diabetes take no medication for it.
Read guide